NCT04975087

Brief Summary

Primary Sjögren's syndrome (pSS) is a chronic, systemic autoimmune disease characterized by disorders of the lacrimal and salivary glands. The disease can be seen in systemic involvement by affecting any organ. It may result in skin, lung and kidney involvement as well as symptoms such as vasculitis and neuropathy. Patients with PSS often report fatigue as an important symptom to manage. Fatigue, defined as an overwhelming feeling of fatigue, lack of energy, and exhaustion, is associated with poor health and functional impairment. Fatigue is a common symptom of pSS. This symptom is the most important cause of loss of function in patients. It is thought that as a result of fatigue in pSS, decrease in mental health related to physical activity level and quality of life in patients, sleep problems, depression and loss of ability to work. Several mechanisms have been proposed to explain the occurrence of fatigue among sjogren patients, but its underlying physiological basis has not been adequately defined. Therefore, it is a complex, multifaceted and poorly understood symptom. In population-based studies, approximately 20% of healthy adults report experiencing fatigue, and this rate rises to 60%-70% among patients with autoimmune disorders. Fatigue is the most common non-exocrine symptom in pSS, and the prevalence of fatigue disability among patients with pSS has been reported to be approximately 70%.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

October 15, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2022

Completed
Last Updated

October 6, 2021

Status Verified

October 1, 2021

Enrollment Period

8 months

First QC Date

July 15, 2021

Last Update Submit

October 5, 2021

Conditions

Keywords

sjogrenvalidityreliabilityfatiguesicca symptoms

Outcome Measures

Primary Outcomes (1)

  • the Profile of Fatigue and Discomfort - Sicca Symptoms Inventory

    It is scored between 0-7 on an 8-point Likert scale. The 19-item scale evaluates patients in 8 different dimensions: somatic fatigue, mental fatigue, arthralgia, vascular dysfunction, oral dryness, ocular dryness, cutaneous and vaginal dryness.

    10 minutes

Study Arms (1)

Patients group

Individuals with primary Sjögren's syndrome

Other: Patients group

Interventions

Patients will complete the mentioned questionnaires.

Patients group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with primary Sjögren's syndrome between the ages of 18-85

You may qualify if:

  • Diagnosed with primary Sjögren's syndrome
  • Patients between the ages of 18-65
  • Being literate

You may not qualify if:

  • Having cognitive disorders
  • Having another rheumatological diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University

Çankaya, Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Fatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Deran OSKAY, Prof

    Gazi University

    STUDY DIRECTOR

Central Study Contacts

Fulden SARİ, doctorate

CONTACT

Deran OSKAY, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research assistant

Study Record Dates

First Submitted

July 15, 2021

First Posted

July 23, 2021

Study Start

October 15, 2021

Primary Completion

June 15, 2022

Study Completion

December 30, 2022

Last Updated

October 6, 2021

Record last verified: 2021-10

Locations